Signaling Pathways - Ubiquitin-specific proteases - Insulin and Insulin-like Receptors - Farnesoid X receptors (FXRs) - MET
清除全部
- B4888 Obeticholic Acid2 Citation中文名: 奥贝胆酸Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR2抑制剂
- B1528 XL335Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met(野生型/突变型)抑制剂
- A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met抑制剂
- A5703 BMS-777607Target: METSummary: 强效的c-Met选择性抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂